Conservators: Psychotropic Medications
Amends Probate Code section 2356.5 to clarify the need for specific authority to administer psychotropic
medications for conservatees with dementia. RESOLUTIONS COMMITTEE
No similar resolutions found.
This resolution amends Probate Code section 2356.5 to clarify the need for specific authority to administer
psychotropic medications for conservatees with dementia. This resolution should be disapproved because
“psychotropic” medications are not specifically identified. Adding the term “psychotropic” could further confuse
courts, if a problem in fact exists.
The proponent has not shown that a real problem exists because some attorneys are unsure when to request
dementia powers. If a problem does exist, the proposed resolution does not fix it as “psychotropic
medications” are not specifically identified in the probate code or other recognized publications for courts and
attorneys to rely upon. Therefore, greater problems would be created. The purpose of the code section is not
to limit appropriate medications for the conservatee with dementia, but to make sure the best interests of the
conservatee are considered, by a doctor completing the capacity declaration form, by court appointed counsel
investigating the allegations and by counsel reporting to the court. The court can then approve the need to
authorize dementia medication. In this area, the law should err, if anything, on the side of protecting the
conservatee. Unfortunately, conservatorships are expensive by their very nature and require oversight to
protect the rights of the conservatee. SECTION/COMMITTEE REPORTS
TRUSTS & ESTATES COMMITTEE RECOMMENDATION
At the time that Probate Code §2356.5 was adopted, the use of the term “psychotropic” was considered,
but rejected because of the difficulty in defining a “psychotropic” medication. Although the proponent
states that Aricept, for instance, would not be considered a “psychotropic” medication, some people would
define it as such. It is important that conservatees not be administered potentially mind altering
medications for dementia without specific safeguards such as those set forth in Probate Code §2356.5
and this resolution would improperly dilute the safeguards now in place. This position is only that of the Trusts and Estates Section of the State Bar of California. This position has
not been adopted by either the State Bar's Board of Governors or overall membership, and is not to be
construed as representing the position of the State Bar of California. Membership in the Trusts and
Estates Section is voluntary and funding for section activities, including all legislative activities, is obtained
entirely from voluntary sources.
TEXT OF RESOLUTION
RESOLVED, that the Conference of Delegates of California Bar Associations recommends that legislation
be sponsored to amend Probate Code section 2356.5 to read as follows:
(a) The Legislature hereby finds and declares:
(1) That people with dementia, as defined in the last published edition of the "Diagnostic and
Statistical Manual of Mental Disorders," should have a conservatorship to serve their unique and
(2) That, by adding powers to the probate conservatorship for people with dementia, their
unique and special needs can be met. This will reduce costs to the conservatee and the family of the
conservatee, reduce costly administration by state and county government, and safeguard the basic
(3) That it is the intent of the Legislature to recognize that the administration of psychotropic
medications has been, and can be, abused by caregivers and, therefore, granting powers to a
conservator to authorize these medications for the treatment of dementia requires the protections
(b) Notwithstanding any other provision of law, a conservator may authorize the placement of
a conservatee in a secured perimeter residential care facility for the elderly operated pursuant to
Section 1569.698 of the Health and Safety Code, or a locked and secured nursing facility which
specializes in the care and treatment of people with dementia pursuant to subdivision (c) of Section
1569.691 of the Health and Safety Code, and which has a care plan that meets the requirements of
Section 87724 of Title 22 of the California Code of Regulations, upon a court's finding, by clear and
convincing evidence, of all of the following:
(1) The conservatee has dementia, as defined in the last published edition of the "Diagnostic
and Statistical Manual of Mental Disorders."
(2) The conservatee lacks the capacity to give informed consent to this placement and has at
least one mental function deficit pursuant to subdivision (a) of Section 811, and this deficit
significantly impairs the person's ability to understand and appreciate the consequences of his or her
actions pursuant to subdivision (b) of Section 811.
(3) The conservatee needs or would benefit from a restricted and secure environment, as
demonstrated by evidence presented by the physician or psychologist referred to in paragraph (3) of
(4) The court finds that the proposed placement in a locked facility is the least restrictive
placement appropriate to the needs of the conservatee.
(c) Notwithstanding any other provision of law, a conservator of a person may authorize the
administration of psychotropic medications appropriate for the care and treatment of dementia, upon
a court's finding, by clear and convincing evidence, of all of the following:
(1) The conservatee has dementia, as defined in the last published edition of the "Diagnostic
and Statistical Manual of Mental Disorders."
(2) The conservatee lacks the capacity to give informed consent to the administration of
psychotropic medications appropriate to the care of dementia, and has at least one mental function
deficit pursuant to subdivision (a) of Section 811, and this deficit or deficits significantly impairs the
person's ability to understand and appreciate the consequences of his or her actions pursuant to
(3) The conservatee needs or would benefit from appropriate medication as demonstrated by
evidence presented by the physician or psychologist referred to in paragraph (3) of subdivision (f).
(d) Pursuant to subdivision (b) of Section 2355, in the case of a person who is an adherent of
a religion whose tenets and practices call for a reliance on prayer alone for healing, the treatment
required by the conservator under subdivision (c) shall be by an accredited practitioner of that religion
in lieu of the administration of medications.
(e) A conservatee who is to be placed in a facility pursuant to this section shall not be placed
in a mental health rehabilitation center as described in Section 5675 of the Welfare and Institutions
Code, or in an institution for mental disease as described in Section 5900 of the Welfare and
(f) A petition for authority to act under this section shall be governed by Section 2357, except:
(1) The conservatee shall be represented by an attorney pursuant to Chapter 4 (commencing
(2) The conservatee shall be produced at the hearing, unless excused pursuant to Section
(3) The petition shall be supported by a declaration of a licensed physician, or a licensed
psychologist within the scope of his or her licensure, regarding each of the findings required to be
made under this section for any power requested, except that the psychologist has at least two years
(4) The petition may be filed by any of the persons designated in Section 1891.
(g) The court investigator shall annually investigate and report to the court every two years
pursuant to Sections 1850 and 1851 if the conservator is authorized to act under this section. In
addition to the other matters provided in Section 1851, the conservatee shall be specifically advised
by the investigator that the conservatee has the right to object to the conservator's powers granted
under this section, and the report shall also include whether powers granted under this section are
warranted. If the conservatee objects to the conservator's powers granted under this section, or the
investigator determines that some change in the powers granted under this section is warranted, the
court shall provide a copy of the report to the attorney of record for the conservatee. If no attorney
has been appointed for the conservatee, one shall be appointed pursuant to Chapter 4 (commencing
with Section 1470) of Part 1. The attorney shall, within 30 days after receiving this report, do one of
(1) File a petition with the court regarding the status of the conservatee.
(2) File a written report with the court stating that the attorney has met with the conservatee
and determined that the petition would be inappropriate.
(h) A petition to terminate authority granted under this section shall be governed by Section
(i) Nothing in this section shall be construed to affect a conservatorship of the estate of a
(j) Nothing in this section shall affect the laws that would otherwise apply in emergency
(k) Nothing in this section shall affect current law regarding the power of a probate court to fix
the residence of a conservatee or to authorize medical treatment for any conservatee who has not
(l)(1) Until such time as the conservatorship becomes subject to review pursuant to Section
1850, this section shall not apply to a conservatorship established on or before the effective date of
the adoption of Judicial Council forms that reflect the procedures authorized by this section, or
January 1, 1998, whichever occurs first.
(2) Upon the adoption of Judicial Council forms that reflect the procedures authorized by this
section or January 1, 1998, whichever occurs first, this section shall apply to any conservatorships
(Proposed new language underlined; language to be deleted stricken.)
PROPONENT: San Diego County Bar Association STATEMENT OF REASONS: Existing Law: Existing law does not limit subdivision (c) to psychotropic medications. Resolution: Would limit subdivision (c) to psychotropic medications. The Problem: Prior to 1996, a probate conservator lacked the authority to place a conservatee suffering from dementia in a "secure perimeter" facility, or to authorize the administration of psychotropic medications appropriate to the treatment of dementia. The only remedy at that time if these powers were needed was to petition for an LPS conservatorship. Recognizing that this was an inappropriate tool, the legislature, in 1996, added two "dementia powers" as additional authority available upon a proper showing of need in a standard Probate Conservatorship proceeding. The granting of this optional authority is subject to additional protections and procedures. As for the administration of psychotropic medications, Probate Code section 2356.5 specifically states:
(a) "The legislature specifically finds and declares that is the intent of the Legislature to recognize
that the administration of psychotropic medications has been, and can be, abused by caregivers and,
therefore, granting powers to a conservator to authorize these medications for the treatment of dementia requires the protections specified in this section. (Emphasis added)
The legislative history, and this specific statement in the statute, makes it clear that the additional
procedural steps and protections were for the purpose of preventing the abuse by inappropriate administration of psychotropic medications.
Unfortunately, in another section of Probate Code section 2356.5 (subsection (c)(2)), the
legislature lists as a required finding that the conservatee lacks the capacity to give informed consent to the administration of medications appropriate to the treatment of dementia" (emphasis added). Note the absence of the reference to "psychotropic." Since 1996 several medications "appropriate to the treatment of dementia" (e.g., Aricept; Excelon; Reminyl; Mementine) have come onto the market to treat problems of memory and cognition in Alzheimer's patients. These are not considered psychotropic medications, but function as inhibitors to the enzyme acetylcholinesterase. This has caused some confusion in the courts, significantly exacerbated by the inclusion of the language "appropriate to the treatment of dementia" without reference to pscyhotropics on various Judicial Council forms (GC 313; GC340).
Faced with uncertainty as to whether or not the administration of a drug such as Aricept requires
dementia authority as a "drug appropriate to the treatment of dementia," many elect to request the dementia powers as matter of course. With the appointment of independent counsel required by the Probate Code in requests for dementia authority, this adds significant cost and potential delay to the proceedings. Since the authority once granted is not drug specific, it also may cause a grant of authority to administer psychtropics that is inappropriate to the facts of a specific case, simply to be able to administer memory enhancing medications. The proposed modifications of the code simply add the word "psychotropic" before "medications appropriate to the treatment of dementia" to remove this confusion. This clearly is in harmony with the original legislative intent. IMPACT STATEMENT: This resolution does not affect any other law statute or rule AUTHOR AND/OR PERMANENT CONTACT: Philip P. Lindsley, San Diego Elder Law Center, 4364 Bonita Road, PMB 461, Bonita, CA 91902, voice (619) 235-4357, fax (619) 472-0700, e-mail [email protected]
RESPONSIBLE FLOOR DELEGATE: Philip P. Lindsley
Substance Abuse and Addiction Course Rationale Throughout history, cultures have used psychoactive drugs for various Unit V purposes such as recreation, rituals, ceremonies, and medicinal purposes. A major concern for today’s medical professionals is substance abuse and its effect on society. To live a healthy lifestyle throughout one’s lifespan an understanding of the re
Arent de Gelder 1645 – 1727 Esther en Mordechai schrijven de eerste Poerimbrief olieverf op doek (102 × 152 cm) — ca. 1685 Gemäldegalerie Alte Meister, Dresden Dit werk is gekoppeld aan Esther 9:20 De joodse inwoners van het rijk van de Perzische koning Ahasveros hebben wraak kunnen nemen op hun vijanden, de aanhangers van de listige Haman. Mordechai en Esther vinden dat de ge